Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Carbohydr Polym ; 329: 121798, 2024 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-38286562

RESUMO

Shrimp, a globally consumed perishable food, faces rapid deterioration during storage and marketing, causing nutritional and economic losses. With a rising environmental consciousness regarding conventional plastic packaging, consumers seek sustainable options. Utilizing natural waste resources for packaging films strengthens the food industry. In this context, we aim to create chitosan-based active films by incorporating Terminalia catappa L. leaves extract (TCE) to enhance barrier properties and extend shrimp shelf life under refrigeration. Incorporation of TCE improves mechanical, microstructural, UV, and moisture barrier properties of the chitosan film due to cross-linking interactions, resulting in robust, foldable packaging film. Active TCE film exhibits high antioxidant property due to polyphenols. These films also exhibited low wettability and showed hydrophobicity than neat CH films which is essential for meat packaging. These biodegradable films offer an eco-friendly end-of-life option when buried in soil. TCE-loaded films effectively control spoilage organisms, prevent biochemical spoilage, and maintain shrimp freshness compared to neat CH films during refrigerated condition. The active TCE film retains sensory attributes better than neat chitosan, aligning with consumer preference. The developed edible and active film from waste sources might offer sustainable, alternative packaging material with a lower carbon footprint than petroleum-based sources.


Assuntos
Quitosana , Terminalia , Embalagem de Alimentos/métodos , Quitosana/química , Carne , Alimentos Marinhos
2.
J Nutr Health Aging ; 27(6): 438-447, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37357328

RESUMO

OBJECTIVES: Multicomponent exercise program have shown to improve function and cognition in older adults but studies on pre-frail older adults in the primary care setting are limited. This study aimed i) to evaluate impact of 6 months exercise (Ex) versus complementary effect of 3 months of cognitive stimulation therapy (CST) to 6 months of Ex (Ex+CST) on physical function, muscle mass and cognition versus control group at 3, 6 and 12 months ii) inflammatory biomarkers such as Interleukin-6 (IL-6) and Tumor Necrosis Factor Alpha (TNF-α). DESIGN: Cluster randomised control trial. SETTING AND INTERVENTION: Pre-frail older adults ≥ 65 years attending primary care clinic. Two intervention groups i) Ex 6 months ii) CST 3 months with Ex 6 months. MEASUREMENTS: At 0, 3, 6 and 12 months, questionnaires (on demographics, physical function, cognition, and depression) were administered and physical function assessment (gait speed, short physical performance battery (SPPB) test, handgrip strength, five times sit-to-stand (5x-STS)) was conducted. Muscle mass and its surrogates such as phase angle and body cell mass were measured using bioelectrical impedance analysis machine. Inflammatory biomarkers were measured at 0 and 3 months. RESULTS: Data from 190 participants was analysed at 3 months (111 control, 37 Ex and 41 Ex+CST). At 3 months, significant improvement in cognition was seen only in the Ex+CST group whereas improvements in depression, gait speed, SPPB and 5x-STS were seen in both the Ex and Ex+CST groups. At 6 months, the Ex+CST group improved in cognition and depression whereas improvement in frailty and muscle mass indices were seen in both the interventions groups. At 12 months, both the interventions groups had better perceived health, gait speed and less decline in muscle mass compared with control groups. Both the Ex and Ex+CST had significant association with TNF-α at 3 months (ß -2.71 (95% CI -4.80 - -0.62); p = 0.012 and ß -1.74 (95% CI -3.43 - -0.06); p = 0.043 respectively). CONCLUSION: Combined Ex+CST had significant improvement in cognition whereas the intervention groups improved in depression, physical function, muscle mass, frailty, perceived health and TNF-α levels. With growing evidence of the benefits of multicomponent interventions at primary care level, incorporating it into mainstream care with action plans on long-term sustainability and scalability should be a priority for every country.


Assuntos
Idoso Fragilizado , Fragilidade , Humanos , Idoso , Idoso Fragilizado/psicologia , Força da Mão , Fator de Necrose Tumoral alfa , Cognição/fisiologia , Músculos , Atenção Primária à Saúde
3.
J Biol Chem ; 276(36): 33369-74, 2001 Sep 07.
Artigo em Inglês | MEDLINE | ID: mdl-11441006

RESUMO

Protection of heart against ischemia-reperfusion injury by ischemic preconditioning and K(ATP) channel openers is known to involve the mitochondrial ATP-sensitive K(+) channel (mitoK(ATP)). Brain is also protected by ischemic preconditioning and K(ATP) channel openers, and it has been suggested that mitoK(ATP) may also play a key role in brain protection. However, it is not known whether mitoK(ATP) exists in brain mitochondria, and, if so, whether its properties are similar to or different from those of heart mitoK(ATP). We report partial purification and reconstitution of a new mitoK(ATP) from rat brain mitochondria. We measured K(+) flux in proteoliposomes and found that brain mitoK(ATP) is regulated by the same ligands as those that regulate mitoK(ATP) from heart and liver. We also examined the effects of opening and closing mitoK(ATP) on brain mitochondrial respiration, and we estimated the amount of mitoK(ATP) by means of green fluorescence probe BODIPY-FL-glyburide labeling of the sulfonylurea receptor of mitoK(ATP) from brain and liver. Three independent methods indicate that brain mitochondria contain six to seven times more mitoK(ATP) per milligram of mitochondrial protein than liver or heart.


Assuntos
Trifosfato de Adenosina/metabolismo , Encéfalo/metabolismo , Proteínas de Membrana/biossíntese , Proteínas de Membrana/química , Mitocôndrias/metabolismo , Canais de Potássio/química , Animais , Antiarrítmicos/farmacologia , Compostos de Boro/farmacologia , Cromakalim/farmacologia , Ácidos Decanoicos/farmacologia , Diazóxido/farmacologia , Corantes Fluorescentes/farmacologia , Glibureto/farmacologia , Guanosina Trifosfato/metabolismo , Hidroxiácidos/farmacologia , Cinética , Ligantes , Fígado/metabolismo , Mitocôndrias Hepáticas/metabolismo , Modelos Biológicos , Miocárdio/metabolismo , Consumo de Oxigênio , Proteolipídeos/metabolismo , Ratos , Fatores de Tempo , Vasodilatadores/farmacologia
4.
Nat Biotechnol ; 19(4): 336-41, 2001 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-11283591

RESUMO

A prototype biosensor array has been assembled from engineered RNA molecular switches that undergo ribozyme-mediated self-cleavage when triggered by specific effectors. Each type of switch is prepared with a 5'-thiotriphosphate moiety that permits immobilization on gold to form individually addressable pixels. The ribozymes comprising each pixel become active only when presented with their corresponding effector, such that each type of switch serves as a specific analyte sensor. An addressed array created with seven different RNA switches was used to report the status of targets in complex mixtures containing metal ion, enzyme cofactor, metabolite, and drug analytes. The RNA switch array also was used to determine the phenotypes of Escherichia coli strains for adenylate cyclase function by detecting naturally produced 3',5'- cyclic adenosine monophosphate (cAMP) in bacterial culture media.


Assuntos
Técnicas Biossensoriais/métodos , Técnicas Genéticas , Ácidos Nucleicos/química , RNA/química , RNA/metabolismo , Adenilil Ciclases/metabolismo , Sítio Alostérico , AMP Cíclico/metabolismo , DNA/química , DNA/metabolismo , Relação Dose-Resposta a Droga , Escherichia coli/metabolismo , Ouro/química , Cinética , Conformação de Ácido Nucleico , Análise de Sequência com Séries de Oligonucleotídeos/métodos , Fenótipo , RNA Catalítico/metabolismo , Silício/química , Fatores de Tempo
5.
Am J Physiol Heart Circ Physiol ; 280(2): H649-57, 2001 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-11158963

RESUMO

There is an emerging consensus that pharmacological opening of the mitochondrial ATP-sensitive K(+) (K(ATP)) channel protects the heart against ischemia-reperfusion damage; however, there are widely divergent views on the effects of openers on isolated heart mitochondria. We have examined the effects of diazoxide and pinacidil on the bioenergetic properties of rat heart mitochondria. As expected of hydrophobic compounds, these drugs have toxic, as well as pharmacological, effects on mitochondria. Both drugs inhibit respiration and increase membrane proton permeability as a function of concentration, causing a decrease in mitochondrial membrane potential and a consequent decrease in Ca(2+) uptake, but these effects are not caused by opening mitochondrial K(ATP) channels. In pharmacological doses (<50 microM), both drugs open mitochondrial K(ATP) channels, and resulting changes in membrane potential and respiration are minimal. The increased K(+) influx associated with mitochondrial K(ATP) channel opening is approximately 30 nmol. min(-1). mg(-1), a very low rate that will depolarize by only 1-2 mV. However, this increase in K(+) influx causes a significant increase in matrix volume. The volume increase is sufficient to reverse matrix contraction caused by oxidative phosphorylation and can be observed even when respiration is inhibited and the membrane potential is supported by ATP hydrolysis, conditions expected during ischemia. Thus opening mitochondrial K(ATP) channels has little direct effect on respiration, membrane potential, or Ca(2+) uptake but has important effects on matrix and intermembrane space volumes.


Assuntos
Trifosfato de Adenosina/metabolismo , Metabolismo Energético/fisiologia , Mitocôndrias/metabolismo , Traumatismo por Reperfusão Miocárdica/metabolismo , Miocárdio/metabolismo , Canais de Potássio/metabolismo , Animais , Ânions/metabolismo , Respiração Celular/efeitos dos fármacos , Respiração Celular/fisiologia , Diazóxido/toxicidade , Metabolismo Energético/efeitos dos fármacos , Ativação do Canal Iônico/efeitos dos fármacos , Ativação do Canal Iônico/fisiologia , Potenciais da Membrana/fisiologia , Mitocôndrias/efeitos dos fármacos , Dilatação Mitocondrial/efeitos dos fármacos , Dilatação Mitocondrial/fisiologia , Pinacidil/toxicidade , Potássio/metabolismo , Ratos , Ácido Succínico/metabolismo , Desacopladores/toxicidade , Vasodilatadores/toxicidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA